• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

趋化因子清除受体 D6 限制体内急性毒性肝损伤。

The chemokine scavenging receptor D6 limits acute toxic liver injury in vivo.

机构信息

Medical Department III, University Hospital Aachen, D-52074 Aachen, Germany.

出版信息

Biol Chem. 2009 Oct;390(10):1039-45. doi: 10.1515/BC.2009.119.

DOI:10.1515/BC.2009.119
PMID:19642876
Abstract

The chemokine decoy receptor D6 is a promiscuous chemokine receptor lacking classical signaling functions. It negatively regulates inflammation by targeting CC chemokines to cellular internalization and degradation. Here we analyze the function of D6 in acute CCl(4)-induced liver damage in constitutive D6(-/-) and wild-type mice. The degree of liver injury was assessed by liver histology, serum transaminases, IL-6, and TNFalpha mRNA expression. Protein levels of D6 ligands (CCL2, CCL3, CCL5) and the non-D6-ligand CXCL9 within the livers were determined by ELISAs. The intrahepatic infiltration of immune cells was characterized by FACS. Genetic deletion of D6 led to prolonged liver damage after acute CCl(4) administration. The augmented liver damage in D6(-/-) mice was associated with increased protein levels of intrahepatic inflammatory chemokines CCL2, CCL3, and CCL5 after 48 h, whereas CXCL9 was not different between knockout and wild-type mice. Functionally, increased intra-hepatic CC chemokine concentrations led to increased infiltration of CD45(+) leukocytes, which were mainly identified as T and NK cells. In conclusion, the chemokine scavenger receptor D6 has a non-redundant role in acute toxic liver injury in vivo. These results support the importance of post-translational chemokine regulation and describe a new mechanism of immune modulation within the liver.

摘要

趋化因子诱饵受体 D6 是一种混杂的趋化因子受体,缺乏经典的信号转导功能。它通过将 CC 趋化因子靶向细胞内化和降解来负调控炎症。在这里,我们分析了 D6 在 CCl(4)诱导的急性肝损伤中的功能缺失,在组成性 D6(-/-)和野生型小鼠中进行了分析。通过肝组织学、血清转氨酶、IL-6 和 TNFalpha mRNA 表达来评估肝损伤的程度。通过 ELISA 测定肝脏中 D6 配体(CCL2、CCL3、CCL5)和非 D6 配体 CXCL9 的蛋白水平。通过 FACS 对肝内免疫细胞的浸润进行了表征。D6 的遗传缺失导致急性 CCl(4)给药后肝脏损伤延长。D6(-/-)小鼠的肝损伤加剧与 48 小时后肝内炎症趋化因子 CCL2、CCL3 和 CCL5 的蛋白水平增加有关,而 CXCL9 在敲除和野生型小鼠之间没有差异。功能上,肝内 CC 趋化因子浓度的增加导致 CD45(+)白细胞的浸润增加,这些白细胞主要被鉴定为 T 和 NK 细胞。总之,趋化因子清除受体 D6 在体内急性毒性肝损伤中具有非冗余作用。这些结果支持了翻译后趋化因子调节的重要性,并描述了肝脏内免疫调节的新机制。

相似文献

1
The chemokine scavenging receptor D6 limits acute toxic liver injury in vivo.趋化因子清除受体 D6 限制体内急性毒性肝损伤。
Biol Chem. 2009 Oct;390(10):1039-45. doi: 10.1515/BC.2009.119.
2
The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myocardial infarction.趋化因子诱饵受体 D6 可预防心肌梗死后过度炎症和不良心室重构。
Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2206-13. doi: 10.1161/ATVBAHA.112.254409. Epub 2012 Jul 12.
3
The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.淋巴系统通过趋化因子诱饵受体 D6 控制肠道炎症和炎症相关的结肠癌。
Gut. 2010 Feb;59(2):197-206. doi: 10.1136/gut.2009.183772. Epub 2009 Oct 20.
4
Thromboxane A(2) receptor signaling promotes liver tissue repair after toxic injury through the enhancement of macrophage recruitment.血栓素 A(2) 受体信号通过增强巨噬细胞募集促进毒性损伤后的肝组织修复。
Toxicol Appl Pharmacol. 2012 Feb 15;259(1):104-14. doi: 10.1016/j.taap.2011.12.013. Epub 2011 Dec 21.
5
The chemokine receptor D6 has opposing effects on allergic inflammation and airway reactivity.趋化因子受体D6对变应性炎症和气道反应性具有相反的作用。
Am J Respir Crit Care Med. 2007 Feb 1;175(3):243-9. doi: 10.1164/rccm.200606-839OC. Epub 2006 Nov 9.
6
Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor.D6诱饵受体对天然和截短型巨噬细胞源性趋化因子(巨噬细胞源性趋化因子/CC趋化因子配体22)的差异识别与清除
J Immunol. 2004 Apr 15;172(8):4972-6. doi: 10.4049/jimmunol.172.8.4972.
7
Chemokine scavenging by D6: a movable feast?D6对趋化因子的清除作用:一场移动盛宴?
Trends Immunol. 2006 Aug;27(8):381-6. doi: 10.1016/j.it.2006.06.006. Epub 2006 Jun 30.
8
Chemokine decoy receptor d6 plays a negative role in human breast cancer.趋化因子诱饵受体d6在人类乳腺癌中发挥负性作用。
Mol Cancer Res. 2008 Aug;6(8):1276-88. doi: 10.1158/1541-7786.MCR-07-2108.
9
Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6.前沿:由多特异性的假定沉默趋化因子受体D6清除炎症性CC趋化因子
J Immunol. 2003 Mar 1;170(5):2279-82. doi: 10.4049/jimmunol.170.5.2279.
10
The atypical chemokine receptor D6 contributes to the development of experimental colitis.非典型趋化因子受体D6促进实验性结肠炎的发展。
J Immunol. 2009 Apr 15;182(8):5032-40. doi: 10.4049/jimmunol.0802802.

引用本文的文献

1
The mechanism of chemokine receptor ACKR2 in cognitive impairment in young rats with traumatic brain injury.趋化因子受体ACKR2在创伤性脑损伤幼鼠认知功能障碍中的作用机制
Am J Transl Res. 2023 Mar 15;15(3):1654-1666. eCollection 2023.
2
The scavenging chemokine receptor ACKR2 has a significant impact on acute mortality rate and early lesion development after traumatic brain injury.趋化因子清除受体ACKR2对创伤性脑损伤后的急性死亡率和早期损伤发展有重大影响。
PLoS One. 2017 Nov 27;12(11):e0188305. doi: 10.1371/journal.pone.0188305. eCollection 2017.
3
Renal Protection by Genetic Deletion of the Atypical Chemokine Receptor ACKR2 in Diabetic OVE Mice.
通过基因敲除糖尿病OVE小鼠中的非典型趋化因子受体ACKR2实现肾脏保护
J Diabetes Res. 2016;2016:5362506. doi: 10.1155/2016/5362506. Epub 2015 Dec 20.
4
The atypical chemokine receptor ACKR2 suppresses Th17 responses to protein autoantigens.非典型趋化因子受体ACKR2可抑制Th17对蛋白质自身抗原的反应。
Immunol Cell Biol. 2015 Feb;93(2):167-76. doi: 10.1038/icb.2014.90. Epub 2014 Oct 28.
5
The role of chemokines in hepatitis C virus-mediated liver disease.趋化因子在丙型肝炎病毒介导的肝脏疾病中的作用。
Int J Mol Sci. 2014 Mar 18;15(3):4747-79. doi: 10.3390/ijms15034747.
6
Immune regulation by atypical chemokine receptors.非典型趋化因子受体的免疫调节作用。
Nat Rev Immunol. 2013 Nov;13(11):815-29. doi: 10.1038/nri3544.
7
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.国际基础和临床药理学联合会。[更正]。LXXXIX. 趋化因子受体大家族的更新及为非典型趋化因子受体引入新的命名法。
Pharmacol Rev. 2013 Nov 11;66(1):1-79. doi: 10.1124/pr.113.007724. Print 2014.
8
Chemokines, chemokine receptors and the gastrointestinal system.趋化因子、趋化因子受体与胃肠道系统。
World J Gastroenterol. 2013 May 21;19(19):2847-63. doi: 10.3748/wjg.v19.i19.2847.
9
The role of chemokines in acute liver injury.趋化因子在急性肝损伤中的作用。
Front Physiol. 2012 Jun 20;3:213. doi: 10.3389/fphys.2012.00213. eCollection 2012.
10
Hepatocyte proliferation/growth arrest balance in the liver of mice during E. multilocularis infection: a coordinated 3-stage course.多房棘球绦虫感染小鼠肝脏中肝细胞增殖/生长阻滞的平衡:一个协调的 3 阶段过程。
PLoS One. 2012;7(1):e30127. doi: 10.1371/journal.pone.0030127. Epub 2012 Jan 10.